A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Condition:   Hemophilia A Intervention:   Drug: Efanesoctocog Alfa BIVV001 Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT ®
Condition:   Hemophilia Intervention:   Drug: SEVENFACT® Sponsor:   Laboratoire français de Fractionnement et de Biotechnologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials